Enedra Therapeutics Ltd

Flindr Therapeutics

This company develops small molecule inhibitors for the precision treatment of cancer patients with specific tumor and host factors.

iOnctura

The company develops precision small-molecule medicines to treat patients with neglected and hard-to-treat solid tumours and cancers.

Enara Bio

This company develops cancer immunotherapies targeting antigens derived from the dark genome for patients with solid tumours.

Ona Therapeutics

This company develops antibody-drug conjugates to treat patients with advanced and metastatic cancers which have become resistant to existing therapies.

ENB Therapeutics

This biopharmaceutical company develops small molecule endothelin B receptor inhibitors to treat drug-resistant cancers for patients undergoing immunotherapy.

Celleron Therapeutics

This biopharmaceutical company develops precision medicine drugs and companion diagnostics for cancer patients to provide personalised oncology treatments.

Fore Biotherapeutics

This precision oncology company develops targeted therapies for patients with unaddressed cancer mutations, including a specific BRAF inhibitor for advanced solid tumours.

Tango Therapeutics

This biotechnology company develops precision oncology medicines targeting genetic vulnerabilities in cancer cells for patients with solid tumours.